In 2013, the study of Jingwen Zhang revealed that tissue transglutaminase (TTG) blocks the EGFR ubiquitination catalyzed by c-CBL through the interaction with c-CBL, which enhances EGFR signaling and thus promotes the formation of glioma (Zhang J. et al., 2013). The gene discussed is TGM2; the disease is central nervous system cancer.